Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU

Inmaculada Alonso-Abreu, Laura Ramos, Alejandro Hernandez-Camba, Carmen Yagüe-Caballero, Raquel Vicente Lidón, Carlos Taxonera, Miguel A. García-Brenes, Javier P. Gisbert, Maria Chaparro, Lucia Madero Velázquez, Marta Carrillo-Palau, Laura Arranz, Beatriz Castro Senosiain, Irene García de la Filia Molina, María Rojas-Feria, Francisco López Romero-Salazar, Iria Bastón-Rey, María Sánchez-Azofra, Sabino Riestra, Pablo Pérez-Galindo, Silvia Patricia Ortega Moya, Eduard Brunet-Mas, Patricia Sanz Segura, Antonio M. Caballero Mateos, Margalida Calafat, Belén Botella Mateu, Noemí Manceñido Marcos, Iago Rodríguez-Lago, Cristina Suarez Ferrer, Ana Gutiérrezon behalf of the Young Group of GETECCU

Therapeutic Advances in Gastroenterology

Published online on June 23, 2026

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Inflammatory bowel disease (IBD) and celiac disease (CeD) are immune-mediated digestive disorders with shared genetic, immunological, and environmental risk factors.Objectives:This study aimed to assess whether the coexistence of CeD and IBD is ...